Concord Medical Services Holdings Limited
CCM
$5.26
$0.010.21%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.48M | 11.53M | 15.11M | 15.24M | 17.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.48M | 11.53M | 15.11M | 15.24M | 17.51M |
| Cost of Revenue | 14.09M | 14.16M | 17.98M | 18.14M | 20.23M |
| Gross Profit | -2.61M | -2.62M | -2.87M | -2.90M | -2.71M |
| SG&A Expenses | 20.63M | 20.73M | 10.78M | 10.87M | 14.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.72M | 34.89M | 28.76M | 29.01M | 34.75M |
| Operating Income | -23.24M | -23.36M | -13.65M | -13.77M | -17.24M |
| Income Before Tax | -23.09M | -23.20M | -23.29M | -23.50M | -22.29M |
| Income Tax Expenses | -613.80K | -616.80K | -598.90K | -604.10K | -80.10K |
| Earnings from Continuing Operations | -22.48M | -22.59M | -22.70M | -22.89M | -22.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 13.02M | 13.09M | 10.80M | 10.90M | 7.89M |
| Net Income | -9.45M | -9.50M | -11.89M | -12.00M | -14.31M |
| EBIT | -23.24M | -23.36M | -13.65M | -13.77M | -17.24M |
| EBITDA | -19.03M | -19.21M | -9.55M | -9.63M | -13.13M |
| EPS Basic | -64.91 | -65.23 | -81.68 | -82.39 | -98.29 |
| Normalized Basic EPS | -0.33 | -0.33 | -- | -- | -1.37 |
| EPS Diluted | -65.19 | -65.50 | -81.68 | -82.39 | -98.55 |
| Normalized Diluted EPS | -0.33 | -0.33 | -- | -- | -1.37 |
| Average Basic Shares Outstanding | 4.37M | 4.37M | 4.37M | 4.37M | 4.37M |
| Average Diluted Shares Outstanding | 145.60K | 145.60K | 145.60K | 145.60K | 145.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |